PROTAC CDK9 degrader 4

Biorbyt

PROTAC CDK9 degrader 4

10

2411021-01-5

Research Use Only

98.00%

C43H56N10O5

792.97

PROTAC CDK9 degrader 4 is a highly potent CDK9 degrader that targets transcriptional regulation and has potential anticancer activity for the study of acute myelogenous leukemia (AML).

N(CC1=CC=C(NC(=O)N2CCN(CCCCCC3=C4C(C(=O)N(C4)C5C(=O)NC(=O)CC5)=CC=C3)CC2)C=C1)C=6N7C(=C(C(C)C)C=N7)N=C(N[C@@H](CC)CO)C6

-20°C

12352200